At the invitation of the college, Professor Eefjan Breukink from the University of Utrecht in the Netherlands was invited to visit our college for a two-day inspection and exchange from November 8th to 9th.
Eefjan Breukin is an honorary professor at the Key Laboratory of Food Microbiology Technology in Zhejiang Province, and has always been concerned about and supported the development of our school's food discipline. During the visit and inspection, Eefjan Breukin had in-depth communication with Professor Gu Qing's research team members, and developed a strong interest in the team's research fields, progress, and achievements in recent years. At the same time, they also provided valuable suggestions for the team's future development. Both sides also discussed the next step of cooperation plans and are expected to carry out broader and deeper cooperation in the field of international cooperation projects related to bacteriocins.
In addition, Eefjan Breukink delivered an academic report entitled "New antibiotics, where and how to find them" for teachers and students of the college. The report was simple and profound, systematically expounded the action mode and antibacterial target of antibiotic, and fully demonstrated the latest research achievements in the international frontier in this field.
Eefjan Breukink is currently the Director of the Department of Biochemistry and Biophysics at the University of Utrecht in the Netherlands. He has long been engaged in research on the antibacterial mechanism, targets, and cell membrane biology of bacteriocins, and is an internationally renowned expert in the field of bacteriocins. He first discovered the mechanism of Nisin: it binds with the lead molecule Lipid II of bacterial cell walls to form cell membrane pores and kill bacteria (published in Science, 1999); Removing Lipid II from the cell membrane blocks the synthesis of the cell wall (published in Science, 2006). The research results have been published in top international academic journals such as Nature, Science, and PNAS, with a total of 93 papers published and an average of more than 42 citations; Possess 5 patents including Lipid II preparation methods.
